Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
Date:1/20/2010

me to time in Thoratec's public reports filed with the Securities and Exchange Commission, such as those discussed under the heading, "Risk Factors," in Thoratec's most recent annual report on Form 10-K, and in Thoratec's first quarter 2009 quarterly report on Form 10-Q, and as may be updated in subsequent SEC filings. These forward-looking statements speak only as of the date hereof. Thoratec undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.

SOURCE Thoratec Corporation

RELATED LINKS
http://www.thoratec.com

'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Presentation at Canaccord Adams Conference to be Webcast
5. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
6. Thoratec Presentation at Piper Jaffray Conference to be Webcast
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
(Date:6/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... license agreement with AbbVie (NYSE: ABBV ) to ... with Halozyme,s ENHANZE ™ platform. ... will receive an initial $23 million payment, followed ... each of up to nine collaboration targets. These ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 A ... additional precautions on product labels underscores the importance ... according to the American Society for Dermatologic Surgery ... include new warnings about the risks for serious ... vessels. While product labels already include information about ...
(Date:6/3/2015)... Loma Linda University Health and Adventist ... Gorgonio Memorial Hospital (SGMH). The SGMH board voted unanimously ... , “Loma Linda University Health has been serving the ... executive officer, Loma Linda University Medical Center. “We are ... to this community.” , Under the proposed affiliation, ...
(Date:6/3/2015)... June 03, 2015 Johnson & Johnson ... $7.8 million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... the company allegedly used to market the antipsychotic drug. ... indicate that the Arkansas Attorney General moved to dismiss ... accord. The Risperdal settlement amounts to just a fraction ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 The ... to announce that Maria C. Savoia, M.D., Dean of Medical ... of Medicine, will become Chair on July 1. ... Chair of the National Resident Matching Program,” said Dr. Savoia. ... reliable process for matching medical students with training programs, and ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
Breaking Medicine News(10 mins):Health News:ASDSA Supports FDA Fillers Directive 2Health News:ASDSA Supports FDA Fillers Directive 3Health News:ASDSA Supports FDA Fillers Directive 4Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3
... stage III colon cancer treated with 5-FU-based chemotherapy after ... improved overall survival with no change in time to ... patients with stage II colon cancer treated after 1995 ... to death compared to those patients treated prior to ...
... ... Days of Intentions to mark the mid-point of 2010. , ... Los Angeles, CA (PRWEB) June 3, 2010 -- This week, Intent.com launches ... Days of Intentions is a challenge to the internet community to commit to posting one new ...
... Davis public health researchers have found that children, who ... choices, are the targets of a new medium used ... an entertaining blend of interactive animation, video content and ... online messages that primarily promote corporate branding and products. ...
... high school, study finds , THURSDAY, June 3 (HealthDay News) ... the two years following high school are less likely to ... , The finding builds on past research that had demonstrated ... and alcohol abuse. , "I,m not saying that we should ...
... but others say it,s not always that simple, , THURSDAY, ... prompts anxiety in many a parent. But having to ... story can make an already sensitive subject even more complicated. ... parents. , As assisted reproduction technology, in which someone other ...
... ... ... 2010 -- Thomas D. Meade, M.D., a nationally renowned knee specialist who has performed ... June 1, Dr. Meade will see patients at Coordinated Health facilities in Allentown, Bethlehem, ...
Cached Medicine News:Health News:Stage II and stage III colon cancer patients treated after 1995 have improved overall survival 2Health News:Intent.com Launches 30 Days of Intentions and Announces Winners of 2010 Intent Web Awards 2Health News:Online games new marketing tool for unhealthy foods 2Health News:Online games new marketing tool for unhealthy foods 3Health News:Romance May Steer Young Adults Away From Booze, Pot 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 3Health News:Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health 2Health News:Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health 3
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: